Sian Bigora, Chief Development Officer at Processa Pharmaceuticals, Inc. (PCSA), bought 1,971 shares at $2.71 ($5K) on 2026-04-30, disclosed to the SEC on 2026-05-19.
Open-market purchase of $5k PCSA by Chief Development Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| PCSA | BUY | 2026-04-01 | $5K | — | Filing → |